Improving eye surface health before cataract surgery with Systane COMPLETE
Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
PHASE4 · National Taiwan University Hospital · NCT06763731
This study tests if using Systane COMPLETE can help people with dry eyes feel better before cataract surgery and improve their surgery results.
Quick facts
| Phase | PHASE4 |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 20 Years to 85 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital (other) |
| Locations | 1 site (Taipei, Taiwan) |
| Trial ID | NCT06763731 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of regular use of Systane COMPLETE in patients with mixed dry eye who are preparing for cataract surgery. The objective is to determine how this treatment may optimize the ocular surface and improve predictions of residual astigmatism post-surgery. Participants aged 20-85 will be monitored for their ability to answer questionnaires and undergo pre-operative assessments. The study aims to enhance surgical outcomes by addressing dry eye symptoms prior to the procedure.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 20-85 with mixed dry eye who require cataract surgery.
Not a fit: Patients with significant ocular surface abnormalities or those currently using dry eye medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and visual acuity for patients undergoing cataract surgery.
How similar studies have performed: Other studies have shown positive outcomes with similar interventions in optimizing ocular surface health before surgery.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The subjects aged 20-85 years, with normal cognitive function and capable of answering related questionnaires who require phacoemulsification and intraocular lens implantation under topical anaesthesia, are the eligible candidates. Exclusion Criteria: 1. Unable to answer the questions in the dry eye survey. 2. Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts. 3. Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect 4. Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin. 5. Using dry eye medication at screening stage
Where this trial is running
Taipei, Taiwan
- National Taiwan University Hospital — Taipei, Taiwan, Taiwan (RECRUITING)
Study contacts
- Study coordinator: Chiun Ho Hou, Ph.D
- Email: chiunhohou@gmail.com
- Phone: +88623123456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ophthalmology, Dry eye, Cataract surgery